All Stories

  1. A machine learning‐derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial

    Article • European Journal of Heart Failure, April 2023, Wiley

    Dr Pierpaolo Pellicori

  2. Congestion and Use of Diuretics in Heart Failure and Cardiomyopathies: a Practical Guide

    Article • Current Cardiology Reports, April 2023, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  3. Urinary Proteomic Signature of Mineralocorticoid Receptor Antagonism by Spironolactone: Evidence from the Randomized-Controlled HOMAGE and PRIORITY Trials

    Article • April 2023, Cold Spring Harbor Laboratory Press

    Dr Pierpaolo Pellicori

  4. Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials

    Article • International Journal of Cardiology, April 2023, Elsevier

    Dr Pierpaolo Pellicori

  5. Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity

    Article • Clinical Research in Cardiology, March 2023, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  6. Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis

    Article • European Journal of Heart Failure, March 2023, Wiley

    Dr Pierpaolo Pellicori

  7. Redefining both iron deficiency and anaemia in cardiovascular disease

    Article • European Heart Journal, March 2023, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  8. Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial)

    Article • The American Journal of Cardiology, March 2023, Elsevier

    Dr Pierpaolo Pellicori

  9. Estimating nuclear scanning capacity requirements for patients with suspected cardiac transthyretin amyloidosis

    Article • ESC Heart Failure, February 2023, Wiley

    Dr Pierpaolo Pellicori

  10. Editorial: Edema in heart failure with reduced ejection fraction

    Article • Frontiers in Cardiovascular Medicine, February 2023, Frontiers

    Dr Pierpaolo Pellicori

  11. The incremental value of multi-organ assessment of congestion using ultrasound in outpatients with heart failure

    Article • European Heart Journal - Cardiovascular Imaging, January 2023, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  12. Identification and quantification of congestion in heart failure: a work in progress

    Article • European Journal of Heart Failure, December 2022, Wiley

    Dr Pierpaolo Pellicori

  13. Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications

    Article • Clinical Research in Cardiology, December 2022, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  14. Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, November 2022, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  15. Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications

    Article • Clinical Research in Cardiology, November 2022, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  16. Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials

    Article • European Journal of Heart Failure, November 2022, Wiley

    Dr Pierpaolo Pellicori

  17. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

    Article • The Lancet, November 2022, Elsevier

    Dr Pierpaolo Pellicori

  18. Ketone Bodies in Acute Heart Failure: Fuel for Thought

    Article • Journal of Cardiac Failure, November 2022, Elsevier

    Dr Pierpaolo Pellicori

  19. Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial

    Article • Clinical Research in Cardiology, October 2022, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  20. Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials

    Article • Clinical Research in Cardiology, October 2022, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  21. Chronic kidney disease (CKD) and CKD ‐ism in heart failure – what a mess!

    Article • European Journal of Heart Failure, October 2022, Wiley

    Dr Pierpaolo Pellicori

  22. Optimal Management of Heart Failure and Chronic Obstructive Pulmonary Disease: Clinical Challenges

    Article • International Journal of General Medicine, October 2022, Taylor & Francis

    Dr Pierpaolo Pellicori

  23. Reply to ‘Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease’

    Article • European Journal of Heart Failure, September 2022, Wiley

    Dr Pierpaolo Pellicori

  24. Albuminuria as a marker of systemic congestion in patients with heart failure

    Article • European Heart Journal, September 2022, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  25. Dyskalemia in people at increased risk for heart failure: findings from the heart ‘OMics’ in AGEing (HOMAGE) trial

    Article • ESC Heart Failure, September 2022, Wiley

    Dr Pierpaolo Pellicori

  26. Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions

    Article • Cardiovascular Research, August 2022, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  27. Rationale and design of a randomised trial of intravenous iron in patients with heart failure

    Article • Heart, August 2022, BMJ

    Dr Pierpaolo Pellicori

  28. Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure

    Article • European Journal of Heart Failure, July 2022, Wiley

    Dr Pierpaolo Pellicori

  29. The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial

    Article • European Journal of Heart Failure, July 2022, Wiley

    Dr Pierpaolo Pellicori

  30. Dynamic risk stratification using Markov chain modelling in patients with chronic heart failure

    Article • ESC Heart Failure, June 2022, Wiley

    Dr Pierpaolo Pellicori

  31. Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure?

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, June 2022, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  32. Remote laser-speckle sensing of heart sounds for health assessment and biometric identification

    Article • Biomedical Optics Express, June 2022, Optical Society of America (OSA)

    Dr Pierpaolo Pellicori

  33. Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo‐controlled multicentre trial

    Article • European Journal of Heart Failure, June 2022, Wiley

    Dr Pierpaolo Pellicori

  34. Heart failure: age is no excuse for complacency

    Article • European Journal of Heart Failure, May 2022, Wiley

    Dr Pierpaolo Pellicori

  35. Chronic Obstructive Pulmonary Disease and Heart Failure

    Article • Cardiology Clinics, May 2022, Elsevier

    Dr Pierpaolo Pellicori

  36. Predicting mortality after hospitalisation for COPD using electronic health records

    Article • Pharmacological Research, May 2022, Elsevier

    Dr Pierpaolo Pellicori

  37. Practical outpatient management of worsening chronic heart failure

    Article • European Journal of Heart Failure, April 2022, Wiley

    Dr Pierpaolo Pellicori

  38. Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank

    Article • European Journal of Heart Failure, April 2022, Wiley

    Dr Pierpaolo Pellicori

  39. Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction

    Article • ESC Heart Failure, April 2022, Wiley

    Dr Pierpaolo Pellicori

  40. Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice

    Article • European Journal of Heart Failure, March 2022, Wiley

    Dr Pierpaolo Pellicori

  41. Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial

    Article • European Journal of Heart Failure, March 2022, Wiley

    Dr Pierpaolo Pellicori

  42. Criteria for Iron Deficiency in Patients With Heart Failure

    Article • Journal of the American College of Cardiology, February 2022, Elsevier

    Dr Pierpaolo Pellicori

  43. Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomised trials

    Article • Pharmacological Research, February 2022, Elsevier

    Dr Pierpaolo Pellicori

  44. Assessment of Phasic Changes of Vascular Size by Automated Edge Tracking-State of the Art and Clinical Perspectives

    Article • Frontiers in Cardiovascular Medicine, January 2022, Frontiers

    Dr Pierpaolo Pellicori

  45. Prognostic Value and Therapeutic Utility of Lung Ultrasound in Acute and Chronic Heart Failure

    Article • JACC Cardiovascular Imaging, January 2022, Elsevier

    Dr Pierpaolo Pellicori

  46. Hypochloraemia following admission to hospital with heart failure is common and associated with an increased risk of readmission or death: a report from OPERA-HF

    Article • European Heart Journal Acute Cardiovascular Care, December 2021, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  47. Biomarker‐based assessment of collagen cross‐linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

    Article • European Journal of Heart Failure, December 2021, Wiley

    Dr Pierpaolo Pellicori

  48. The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial

    Article • Journal of Cardiac Failure, December 2021, Elsevier

    Dr Pierpaolo Pellicori

  49. No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial

    Article • Archives of Cardiovascular Diseases, December 2021, Elsevier

    Dr Pierpaolo Pellicori

  50. The effect of digoxin on renal function in patients with heart failure

    Article • BMC Nephrology, October 2021, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  51. The prevalence and clinical associations of ultrasound measures of congestion in patients at risk of developing heart failure

    Article • European Journal of Heart Failure, October 2021, Wiley

    Dr Pierpaolo Pellicori

  52. Congestion in Patients with Advanced Heart Failure

    Article • Heart Failure Clinics, October 2021, Elsevier

    Dr Pierpaolo Pellicori

  53. To master heart failure, first master congestion

    Article • The Lancet, September 2021, Elsevier

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  54. Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: Implications for future trial design

    Article • Diabetes & Metabolism, September 2021, Elsevier

    Dr Pierpaolo Pellicori

  55. Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial

    Article • Cardiovascular Diabetology, August 2021, Springer Science + Business Media

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  56. A novel treatment for heart failure targets myocardial fibrosis

    Article • Nature Reports Stem Cells, August 2021, Springer Science + Business Media

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  57. Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening

    Article • BMJ Open Diabetes Research & Care, August 2021, BMJ

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  58. Use of Social Media by Cardiovascular Health Care Professionals

    Article • JACC Cardiovascular Imaging, August 2021, Elsevier

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  59. Reply to the letter regarding the article ‘Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure’

    Article • European Journal of Heart Failure, July 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  60. Remote history of VTE is associated with severe COVID‐19 in middle and older age: UK Biobank cohort study

    Article • Journal of Thrombosis and Haemostasis, July 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  61. A comparison of non‐invasive methods of measuring body composition in patients with heart failure: a report from SICA‐HF

    Article • ESC Heart Failure, July 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  62. Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure

    Article • European Journal of Heart Failure, May 2021, Wiley

    Dr Pierpaolo Pellicori

  63. Use of diuretics and outcomes in patients with type 2 diabetes: Findings from the EMPA‐REG OUTCOME trial

    Article • European Journal of Heart Failure, May 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  64. Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, April 2021, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  65. The struggle towards a Universal Definition of Heart Failure—how to proceed?

    Article • European Heart Journal, April 2021, Oxford University Press (OUP)

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  66. Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF

    Article • JACC Heart Failure, April 2021, Elsevier

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  67. Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials

    Article • Clinical Research in Cardiology, March 2021, Springer Science + Business Media

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  68. Prognostic value of the chest X-ray in patients hospitalised for heart failure

    Article • Clinical Research in Cardiology, March 2021, Springer Science + Business Media

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  69. The value of spot urinary creatinine as a marker of muscle wasting in patients with new‐onset or worsening heart failure

    Article • Journal of Cachexia Sarcopenia and Muscle, March 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  70. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies

    Article • Cochrane Database of Systematic Reviews, March 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  71. The Effect of Digoxin on Renal Function in Patients with Heart Failure

    Article • February 2021, Research Square

    Dr Pierpaolo Pellicori

  72. The association between blood groups and COVID‐19 infection: a study from the UK Biobank

    Article • Journal of Internal Medicine, January 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  73. Effect of frailty on treatment, hospitalisation and death in patients with chronic heart failure

    Article • Clinical Research in Cardiology, January 2021, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  74. The impact of malnutrition on short-term morbidity and mortality in ambulatory patients with heart failure

    Article • American Journal of Clinical Nutrition, November 2020, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  75. Ultrasound imaging of congestion in heart failure: examinations beyond the heart

    Article • European Journal of Heart Failure, November 2020, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  76. Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA‐REG OUTCOME

    Article • ESC Heart Failure, September 2020, Wiley

    Dr Pierpaolo Pellicori

  77. Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure: findings from a pooled analysis of four cohort studies

    Article • Clinical Research in Cardiology, August 2020, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  78. Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data

    Article • Therapeutics and Clinical Risk Management, August 2020, Taylor & Francis

    Dr Pierpaolo Pellicori

  79. Structural heart disease, cardiac dysfunction and heart failure: the ambiguity of a definition

    Article • European Journal of Preventive Cardiology, July 2020, SAGE Publications

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  80. Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial

    Article • European Journal of Heart Failure, July 2020, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  81. Driving Habits and Reaction Times on a Driving Simulation in Older Drivers With Chronic Heart Failure

    Article • Journal of Cardiac Failure, July 2020, Elsevier

    Dr Pierpaolo Pellicori

  82. Caring for people with heart failure and many other medical problems through and beyond the COVID ‐19 pandemic: the advantages of universal access to home telemonitoring

    Article • European Journal of Heart Failure, June 2020, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  83. At the heart of COVID-19

    Article • European Heart Journal, May 2020, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  84. Association Between Walking Pace and Stroke Incidence

    Article • Stroke, May 2020, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  85. Ultrasound indices of congestion in patients with acute heart failure according to body mass index

    Article • Clinical Research in Cardiology, April 2020, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  86. Agreement and Classification Performance of Malnutrition Tools in Patients with Chronic Heart Failure

    Article • Current Developments in Nutrition, April 2020, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  87. Eplerenone prevents an increase in serum carboxy‐terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure

    Article • European Journal of Heart Failure, April 2020, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  88. Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing ...

    Article • European Journal of Heart Failure, January 2020, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  89. OUP accepted manuscript

    Article • European Heart Journal, January 2020, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  90. Chronic Obstructive Pulmonary Disease and Heart Failure

    Article • Heart Failure Clinics, January 2020, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  91. Association of Fitness and Grip Strength With Heart Failure

    Article • Mayo Clinic Proceedings, November 2019, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  92. Myocardial Dysfunction and Coronary Artery Disease as Therapeutic Targets in Heart Failure

    Article • Circulation, August 2019, Wolters Kluwer Health

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  93. Prevalence and Incidence of Atrial Fibrillation in Ambulatory Patients with Heart Failure

    Article • The American Journal of Cardiology, August 2019, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  94. High sensitivity C-Reactive Protein in Chronic Heart Failure: Patient Characteristics, Phenotypes and Mode of Death

    Article • Cardiovascular Research, July 2019, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  95. New perspectives and future directions in the treatment of heart failure

    Article • Heart Failure Reviews, July 2019, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  96. Prevention or Procrastination for Heart Failure?

    Article • Journal of the American College of Cardiology, May 2019, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  97. Clinical and prognostic association of total atrial conduction time in patients with heart failure

    Article • Journal of Cardiovascular Medicine, April 2019, Wolters Kluwer Health

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  98. Identification of Frailty in Chronic Heart Failure

    Article • JACC Heart Failure, February 2019, Elsevier

    Dr Pierpaolo Pellicori

  99. Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure

    Article • European Journal of Heart Failure, January 2019, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  100. The prognostic role of different renal function phenotypes in patients with acute heart failure

    Article • International Journal of Cardiology, November 2018, Elsevier

    Dr Pierpaolo Pellicori

  101. Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure

    Article • International Journal of Cardiology, October 2018, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  102. Walking Pace Is Associated with Lower Risk of All-Cause and Cause-Specific Mortality

    Article • Medicine & Science in Sports & Exercise, October 2018, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  103. Warm water immersion in patients with chronic heart failure: a pilot study

    Article • Clinical Research in Cardiology, September 2018, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  104. Malnutrition, congestion and mortality in ambulatory patients with heart failure

    Article • Heart, August 2018, BMJ

    Dr Pierpaolo Pellicori

  105. Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure

    Article • International Journal of Cardiology, August 2018, Elsevier

    Dr Pierpaolo Pellicori

  106. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life

    Article • Clinical Research in Cardiology, July 2018, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  107. Losing Track by Tracking Speckles

    Article • JACC Cardiovascular Imaging, July 2018, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  108. Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis

    Article • Clinical Research in Cardiology, June 2018, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  109. Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance

    Article • European Journal of Heart Failure, June 2018, Wiley

    Dr Pierpaolo Pellicori

  110. Prevalence and Prognostic Significance of Malnutrition Using 3 Scoring Systems Among Outpatients With Heart Failure

    Article • JACC Heart Failure, June 2018, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  111. Effect of increased inspired oxygen on exercise performance in patients with heart failure and normal ejection fraction

    Article • International Journal of Cardiology, May 2018, Elsevier

    Dr Pierpaolo Pellicori

  112. Prognostic value of psychosocial factors for first and recurrent hospitalizations and mortality in heart failure patients: insights from the OPERA-HF study

    Article • European Journal of Heart Failure, January 2018, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  113. Clinical and prognostic relationships of pulmonary artery to aorta diameter ratio in patients with heart failure: a cardiac magnetic resonance imaging study

    Article • Clinical Cardiology, January 2018, Wiley

    Dr Pierpaolo Pellicori

  114. Prevalence, predictors, and prognostic implications of PR interval prolongation in patients with heart failure

    Article • Clinical Research in Cardiology, September 2017, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  115. Time to Take the Failure Out of Heart Failure

    Article • JACC Heart Failure, July 2017, Elsevier

    Dr Pierpaolo Pellicori

  116. Interatrial shunt devices for heart failure with normal ejection fraction: a technology update

    Article • Medical Devices Evidence and Research, June 2017, Dove Medical Press

    Dr Pierpaolo Pellicori

  117. Pharmacological and Non-pharmacological Treatment for Decompensated Heart Failure: What Is New?

    Article • Current Heart Failure Reports, April 2017, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  118. This patient is not breathing properly: is this COPD, heart failure, or neither?

    Article • Expert Review of Cardiovascular Therapy, April 2017, Taylor & Francis

    Dr Pierpaolo Pellicori

  119. Takotsubo syndrome in the paediatric population

    Article • Journal of Cardiovascular Medicine, April 2017, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  120. Non-invasive measurement of right atrial pressure by near-infrared spectroscopy: preliminary experience. A report from the SICA-HF study

    Article • European Journal of Heart Failure, April 2017, Wiley

    Dr Pierpaolo Pellicori

  121. The effects of short-term omission of daily medication on the pathophysiology of heart failure

    Article • European Journal of Heart Failure, March 2017, Wiley

    Dr Pierpaolo Pellicori

  122. New pharmacological approaches in heart failure therapy: developments and possibilities

    Article • Future Cardiology, March 2017, Future Medicine

    Dr Pierpaolo Pellicori

  123. What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?

    Article • European Journal of Heart Failure, February 2017, Wiley

    Dr Pierpaolo Pellicori

  124. Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction

    Article • Clinical Research in Cardiology, February 2017, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  125. Is Swimming Safe in Heart Failure? A Systematic Review

    Article • Cardiology in Review, January 2017, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  126. Renal function estimation and Cockcroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocar...

    Article • BMC Medicine, November 2016, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor john j mcmurray

  127. Cardiac Dysfunction, Congestion and Loop Diuretics: their Relationship to Prognosis in Heart Failure

    Article • Cardiovascular Drugs and Therapy, November 2016, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  128. Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life

    Article • International Journal of Cardiology, November 2016, Elsevier

    Dr Pierpaolo Pellicori

  129. Tachycardia-induced cardiomyopathy in pregnancy

    Article • Journal of Cardiovascular Medicine, October 2016, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  130. PARADIGM-HF: does dose matter?

    Article • European Journal of Heart Failure, October 2016, Wiley

    Dr Pierpaolo Pellicori

  131. Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure

    Article • JAMA Cardiology, August 2016, American Medical Association (AMA)

    Dr Pierpaolo Pellicori

  132. Taxonomy of segmental myocardial systolic dysfunction

    Article • European Heart Journal, May 2016, European Society of Cardiology

    Dr Pierpaolo Pellicori

  133. Regional circulatory distribution of novel cardiac bio-markers and their relationships with haemodynamic measurements

    Article • International Journal of Cardiology, May 2016, Elsevier

    Dr Pierpaolo Pellicori

  134. New ways to visualize and combat congestion in heart failure

    Article • Revista Clínica Española, May 2016, Elsevier

    Dr Pierpaolo Pellicori

  135. Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1

    Article • European Journal of Heart Failure, March 2016, Wiley

    Dr Pierpaolo Pellicori

  136. The effect of increasing inspired oxygen on exercise performance in patients with chronic heart failure

    Article • Heart, February 2016, BMJ

    Dr Pierpaolo Pellicori

  137. Exploring quality of life in patients with and without heart failure

    Article • International Journal of Cardiology, January 2016, Elsevier

    Dr Pierpaolo Pellicori

  138. Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure

    Article • European Journal of Heart Failure, August 2015, Wiley

    Dr Pierpaolo Pellicori

  139. The Prevalence of Iron Deficiency in Patients with Heart Failure with Preserved Ejection Fraction and its Association with Elevated Pulmonary Pressure, Reduced Exercise Capacity and Quality of Life

    Article • Journal of Cardiac Failure, August 2015, Elsevier

    Dr Pierpaolo Pellicori

  140. Prognostic significance of ultrasound-assessed jugular vein distensibility in heart failure

    Article • Heart, May 2015, BMJ

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  141. The Obesity Paradox in Type 2 Diabetes Mellitus: Relationship of Body Mass Index to Prognosis

    Article • Annals of Internal Medicine, May 2015, American College of Physicians

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  142. The relationship of QRS morphology with cardiac structure and function in patients with heart failure

    Article • Clinical Research in Cardiology, April 2015, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  143. If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment?

    Article • Journal of Telemedicine and Telecare, March 2015, SAGE Publications

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  144. Update on management of heart failure with preserved ejection fraction

    Article • Current Opinion in Cardiology, March 2015, Wolters Kluwer Health

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  145. Prescribing Patterns to Optimize Heart Rate

    Article • JACC Heart Failure, March 2015, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  146. Is the Epidemic of Heart Disease Really Over or Just Evolving?

    Article • The American Journal of Medicine, March 2015, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  147. Patent Ductus Arteriosus in Older Adults: Incidental Finding or Relevant Pathology?

    Article • Journal of the American Geriatrics Society, February 2015, Wiley

    Dr Pierpaolo Pellicori

  148. The Prevalence of Extra-cranial Carotid Artery Disease in Chronic Heart Failure

    Article • Cardiology and Angiology An International Journal, January 2015, Sciencedomain International

    Dr Pierpaolo Pellicori

  149. Fluid Management In Patients With Chronic Heart Failure

    Article • January 2015, Medical Media Communications, Ltd. T/A Radcliffe Cardiology

    Dr Pierpaolo Pellicori

  150. Heart failure with preserved ejection fraction

    Article • Clinical Medicine, December 2014, Royal College of Physicians

    Dr Pierpaolo Pellicori

  151. Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM‐HF, CONFIRM‐HF, SIGNIFY, atrial fibrillation, beta‐blockers and heart failure, and vagal stimulation in heart failure

    Article • ESC Heart Failure, November 2014, Wiley

    Dr Pierpaolo Pellicori

  152. Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value

    Article • European Heart Journal, October 2014, European Society of Cardiology

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  153. Lipid-Modifying Treatments for Heart Failure

    Article • Heart Failure Clinics, October 2014, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  154. Does Speckle Tracking Really Improve Diagnosis and Risk Stratification in Patients With HF With Normal EF?

    Article • Journal of the American College of Cardiology, October 2014, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  155. Diagnostic Accuracy of Left Ventricular Systolic Dysfunction in Routine Clinical Practice-Classifying the Unclassified

    Article • Journal of Cardiac Failure, August 2014, Elsevier

    Dr Pierpaolo Pellicori

  156. Muscle Wasting in Patients with Heart Failure with Preserved Ejection Fraction and Its Impact on Muscle Strength and Functional Capacity during Exercise

    Article • Journal of Cardiac Failure, August 2014, Elsevier

    Dr Pierpaolo Pellicori, Professor Wolfram Doehner

  157. Remote telemonitoring for patients with heart failure: might monitoring pulmonary artery pressure become routine?

    Article • Expert Review of Cardiovascular Therapy, July 2014, Taylor & Francis

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  158. Clinical Trials in Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction

    Article • Heart Failure Clinics, July 2014, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  159. Telemonitoring in heart failure: Big Brother watching over you

    Article • Heart Failure Reviews, June 2014, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  160. THE OBESITY PARADOX IN TYPE II DIABETES MELLITUS: IMPACT OF BODY MASS INDEX ON PROGNOSIS

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Pierpaolo Pellicori

  161. Multiple Cardiac Clots in an Individual with Essential Thrombocythemia and Heart Failure

    Article • Journal of the American Geriatrics Society, March 2014, Wiley

    Dr Pierpaolo Pellicori

  162. The in vitro stability of novel cardiovascular and sepsis biomarkers at ambient temperature

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2014, De Gruyter

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  163. Revisiting a classical clinical sign: Jugular venous ultrasound

    Article • International Journal of Cardiology, January 2014, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  164. Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification?

    Article • The International Journal of Cardiovascular Imaging, October 2013, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  165. Case Selection for Cardiac Resynchronization in Atrial Fibrillation

    Article • Heart Failure Clinics, October 2013, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  166. Old and newer biomarkers in heart failure

    Article • Journal of Cardiovascular Medicine, October 2013, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  167. Does cirrhotic cardiomyopathy exist? 50 years of uncertainty

    Article • Clinical Research in Cardiology, September 2013, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  168. Intravenous versus intracoronary bolus of glycoprotein IIb/IIIa inhibitor administration during primary percutaneous coronary intervention on long-term left ventricular systolic and diastolic function

    Article • Cardiology Journal, June 2013, VM Media SP. zo.o VM Group SK

    Dr Pierpaolo Pellicori

  169. Why Does CRT Reduce the Risk of Arrhythmias?

    Article • JACC Cardiovascular Imaging, April 2013, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  170. Fish Oil vs Olive Oil for Postoperative Atrial Fibrillation

    Article • JAMA, March 2013, American Medical Association (AMA)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  171. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease

    Article • European Journal of Internal Medicine, March 2013, Elsevier

    Dr Pierpaolo Pellicori

  172. Defining Diastolic Heart Failure and Identifying Effective Therapies

    Article • JAMA, February 2013, American Medical Association (AMA)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  173. Medical Management of Stable Coronary Atherosclerosis

    Article • Current Atherosclerosis Reports, February 2013, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  174. IVC Diameter in Patients With Chronic Heart Failure

    Article • JACC Cardiovascular Imaging, January 2013, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  175. An atrial mass

    Article • Journal of Cardiovascular Medicine, November 2012, Wolters Kluwer Health

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  176. A Meta-Analysis of the Therapeutic Effects of Glucagon-Like Peptide-1 Agonist in Heart Failure

    Article • International Journal of Peptides, July 2012, Hindawi Publishing Corporation

    Dr Pierpaolo Pellicori

  177. Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis

    Article • Heart Failure Reviews, March 2012, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  178. Subclinical Anthracycline Cardiotoxicity in Patients With Acute Promyelocytic Leukemia in Long‐Term Remission After the AIDA Protocol

    Article • Congestive Heart Failure, January 2012, Wiley

    Dr Pierpaolo Pellicori

  179. Clinical trials update from the American Heart Association Meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT

    Article • European Journal of Heart Failure, April 2011, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  180. Cor triatriatum: Transoesophageal three-dimensional reconstruction shows exact membrane morphology

    Article • Archives of Cardiovascular Diseases, March 2010, Elsevier

    Dr Pierpaolo Pellicori